The results showed a consistent advantage for the combination, and that advantage became more pronounced at higher weight loss thresholds, precisely where GLP-1 therapy tends to be most clinically meaningful: At a 20% weight loss threshold, 45% of women in the combination group achieved this level of loss, compared to 24% in the GLP-1 alone group
Decrease Inflammation GLP-1 has shown to have anti-inflammatory properties that extend to the gut
most were in phase IIIb of anagen, and some were in anagen IV phase, with some melanin around the bulbs, compared to the early anagen phase (anagen IIIIIa) in the control
Patients should be aware that tirzepatide can reduce the effectiveness of oral contraceptives, particularly after starting treatment or increasing doses
injectable semaglutide trials show clearer, larger weight loss emerging by ~1216 weeks
Fish and shellfish are also not to be ignored